NCT04727476 - The Use of Lisdexamfetamine for Children Aged 7-13 With Attention Deficit Disorders | Biotech Hunter

Enrollment

413

Participants

Timeline

Start Date

January 19, 2021

Primary Completion Date

August 10, 2021

Study Completion Date

May 1, 2022

Conditions

Attention Deficit DisorderAttention Deficit Hyperactivity DisorderHyperkinetic Disorder

Interventions

DRUG

Lisdexamfetamine

Prescription of lisdexamfetamine sometime during til period from 1 April 2013 to 5 November 2019.

Trial Locations (1)

Department of Child and Adolescent Psychiatry, Aarhus University Hospital, Aarhus